Est. 2001·3,000+ placements · six offices · four regions
Leadership Changecurated sourcedetected 2026-07-28 · confidence 93%

Last updated

Bicara Therapeutics: Leadership Change

Bicara Therapeutics (Nasdaq: BCAX) appointed biotechnology executives Jeremy Bender and Christy Oliger to Board of Directors as clinical-stage oncology company transitions toward commercialization of lead candidate ficerafusp alfa. Founding board member Kiran Mazumdar-Shaw retired from board.

Source: citybiz — regional US deals

What happened
Bicara Therapeutics (Nasdaq: BCAX) appointed biotechnology executives Jeremy Bender and Christy Oliger to Board of Directors as clinical-stage oncology company transitions toward commercialization of lead candidate ficerafusp alfa. Founding board member Kiran Mazumdar-Shaw retired from board.
Who
Bicara Therapeutics · USA
When
2026-07-28
So what
Commercial operations and go-to-market build-out: Chief Commercial Officer or VP Commercial roles; sales force and market access teams (Bender's background at Day One Biopharmaceuticals pre-Servier acquisition demonstrates commercialization expertise); regulatory and compliance leadership (preparing for regulatory approval and launch); market access and reimbursement specialists (Oliger's $13B+ U.S.

The leadership read

Commercial operations and go-to-market build-out: Chief Commercial Officer or VP Commercial roles; sales force and market access teams (Bender's background at Day One Biopharmaceuticals pre-Servier acquisition demonstrates commercialization expertise); regulatory and compliance leadership (preparing for regulatory approval and launch); market access and reimbursement specialists (Oliger's $13B+ U.S. oncology portfolio experience at Genentech). Manufacturing scale-up and supply chain roles to support commercial launch.

Market context: Against a Talent Market Index of 122.7 (Hot) (up 17.8 month-on-month), Americas is at rising (+34.4pts) on signal share.

Bicara Therapeutics: 2 signals in the last 90 days; 3 tracked across 38 days.

MitchelLake in this thematic

Also at Bicara Therapeutics →

More signals across Americas

Leadership Change · Americas

Central 1 →

Central 1 has named banking veteran Mike Henry as new CEO and president. Henry has over three decades of experience, including more than 25 years at Scotiabank.

Leadership Change · Americas

Griffin →

Griffin appointed David Jenkins as its new CFO; he brings over three decades of financial leadership experience.

Leadership Change · Americas

CBS Mornings →

Jon Tower has been named permanent executive producer of CBS Mornings after serving on an interim basis since earlier in 2026, succeeding Shawna Thomas, who left in March.

Leadership Change · Americas

WFUV →

Veteran media executive Rich McLaughlin was named General Manager of WFUV, Fordham University's public radio station, bringing 25 years of broadcasting and digital media experience.

Leadership Change · Americas

Solenis →

Solenis, a global water treatment, process and hygiene solutions provider, appointed Brendy Lange as Chief Business Officer, Americas, with a mandate to drive growth and customer engagement across the Americas.

Leadership Change · Americas

Position Music →

Position Music hired Pete Robinson, former Big Deal Music and RCA executive, as General Manager, Creative for Nashville, reporting to founder and CEO Tyler Bacon and President Mark Chipello.

Where this lands in our work

Weekly briefing

Track companies like Bicara Therapeutics — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗